258 related articles for article (PubMed ID: 25931431)
1. The Pap test and Bethesda 2014.
Nayar R; Wilbur DC
Cancer Cytopathol; 2015 May; 123(5):271-81. PubMed ID: 25931431
[No Abstract] [Full Text] [Related]
2. A selection of monitoring parameters for gynecologic cytology-Beacons of light for quality assurance.
Auger M
Cancer Cytopathol; 2014 Jan; 122(1):3-4. PubMed ID: 24203215
[No Abstract] [Full Text] [Related]
3. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
Li Z; Austin RM; Guo M; Zhao C
Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
[TBL] [Abstract][Full Text] [Related]
4. The official nomenclature and terminologies in diagnostic cytopathology: history, evolution, applicability and future.
Ali SZ; Leteurtre E
Ann Pathol; 2012 Dec; 32(6):e3-7, 389-93. PubMed ID: 23244483
[No Abstract] [Full Text] [Related]
5. Updates in Cervical Cytology: The 90-Year-Long Journey from Battle Creek to Today.
Roe CJ; Hanley KZ
Surg Pathol Clin; 2018 Sep; 11(3):589-599. PubMed ID: 30190142
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus reporting: impact on Bethesda cytology reports.
Raab SS
Arch Pathol Lab Med; 2003 Aug; 127(8):969-72. PubMed ID: 12873168
[TBL] [Abstract][Full Text] [Related]
7. Primary human papillomavirus screening for cervical cancer in the United States-US Food and Drug Administration approval, clinical trials, and where we are today.
Nayar R; Goulart RA; Tiscornia-Wasserman PG; Davey DD
Cancer Cytopathol; 2014 Oct; 122(10):720-9. PubMed ID: 25228434
[No Abstract] [Full Text] [Related]
8. Atypical glandular cells and risk of cervical cancer.
Burki TK
Lancet Oncol; 2016 Mar; 17(3):e96. PubMed ID: 26907188
[No Abstract] [Full Text] [Related]
9. Case records of the Massachusetts General Hospital. Case 16-2014. A 46-year-old woman in Botswana with postcoital bleeding.
Ramogola-Masire D; Russell AH; Dryden-Peterson S; Efstathiou JA; Kayembe MK; Wilbur DC
N Engl J Med; 2014 May; 370(21):2032-41. PubMed ID: 24849087
[No Abstract] [Full Text] [Related]
10. Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria.
Thrall MJ; Pambuccian SE; Stelow EB; McKeon DM; Miller L; Savik K; Gulbahce HE
Cancer; 2008 Jun; 114(3):171-9. PubMed ID: 18454461
[TBL] [Abstract][Full Text] [Related]
11. Pap smears: interpreting the new Bethesda terminology.
Gore H; Shingleton HM
J Surg Oncol; 1997 Feb; 64(2):95-7. PubMed ID: 9047243
[No Abstract] [Full Text] [Related]
12. George Papanicolaou (1883-1962): Discoverer of the Pap smear.
Tan SY; Tatsumura Y
Singapore Med J; 2015 Oct; 56(10):586-7. PubMed ID: 26512152
[No Abstract] [Full Text] [Related]
13. Cytodiagnosis in cervical neoplasia: from the Babes/Papanicolaou smear to the actual Bethesda System.
Virtej P; Vasiliu C
Clin Exp Obstet Gynecol; 2003; 30(4):173-7. PubMed ID: 14664403
[TBL] [Abstract][Full Text] [Related]
14. Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia.
Zhao C; Li Z; Austin RM
Am J Clin Pathol; 2013 Jul; 140(1):47-54. PubMed ID: 23765533
[TBL] [Abstract][Full Text] [Related]
15. Type 1 and type 2 cervical carcinomas: some cervical cancers are more difficult to prevent with screening.
Austin RM; Zhao C
Cytopathology; 2012 Feb; 23(1):6-12. PubMed ID: 22243288
[TBL] [Abstract][Full Text] [Related]
16. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.
Printz C
Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486
[No Abstract] [Full Text] [Related]
17. The Pap Test and Bethesda 2014: "The reports of my demise have been greatly exaggerated. (after a quotation from Mark Twain)".
Nayar R; Wilbur DC
J Low Genit Tract Dis; 2015 Jul; 19(3):175-84. PubMed ID: 25943863
[TBL] [Abstract][Full Text] [Related]
18. Early histological diagnosis of cervical cancer.
Burghardt E
Major Probl Obstet Gynecol; 1973; 6():1-401. PubMed ID: 4594637
[No Abstract] [Full Text] [Related]
19. Elevated levels of tetraploid cervical cells in human papillomavirus-positive Papanicolaou smears diagnosed as atypical squamous cells of undetermined significance.
Olaharski AJ; Eastmond DA
Cancer; 2004 Jun; 102(3):192-9. PubMed ID: 15211479
[TBL] [Abstract][Full Text] [Related]
20. The role of cytology (Pap tests) and human papillomavirus testing in anal cancer screening.
Salit IE; Lytwyn A; Raboud J; Sano M; Chong S; Diong C; Chapman W; Mahony JB; Tinmouth J
AIDS; 2010 Jun; 24(9):1307-13. PubMed ID: 20442633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
